Company · CIK 0001409012
Abraxis BioScience, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 4Insider trades0001181431-10-051419 · 5.7 KBSEC(opens sec.gov)
- 4Insider trades0001181431-10-051416 · 5.7 KBSEC(opens sec.gov)
- 4Insider trades0001181431-10-051415 · 5.7 KBSEC(opens sec.gov)
- 4Insider trades0001181431-10-051410 · 5.7 KBSEC(opens sec.gov)
- SC 13D/AAbraxis BioScience, Inc.0000950123-10-093953 · 82.3 KBSEC(opens sec.gov)
- 4Insider trades0001209191-10-050700 · 8.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-10-230214 · 23.4 KBSEC(opens sec.gov)
- 10-QQuarterly update0001193125-10-179509 · 696.5 KBSEC(opens sec.gov)
- 3Abraxis BioScience, Inc.0001209191-10-037989 · 9.0 KBSEC(opens sec.gov)
- SC 13DAbraxis BioScience, Inc.0000950123-10-064430 · 105.9 KBSEC(opens sec.gov)
Insiders
- CALHOUN KIRK KDirector
- CELGENE CORP /DE/10% Owner
- CHEN DAVIDDirector
- FOGELMAN MITCHELL KDirector, Chief Financial Officer
- Geehr EdExecutive VP Operations
- Hedley Mary LynneExecutive VP of Ops & CSO
- MOULDER LEON O JRDirector, President & CEO
- NIMER STEPHENDirector
- O'Toole David D.CFO & Executive VP
- Rodgers Richard JSenior Vice President and CFO
Tickers
No tickers on record.
Addresses
business
11755 WILSHIRE BLVD., 20TH FLOOR
LOS ANGELES, CA, 90025
mailing
11755 WILSHIRE BLVD., 20TH FLOOR
LOS ANGELES, CA, 90025
Former names
- Abraxis Biosciences, Inc.2008-09-26
- New Abraxis, Inc.2007-11-19
Same industry